Medical Licensing (MD/DO) · Independent exam preparation
Pain Medicine Examination Study Guide
Practise pain classification, medication safety, procedural selection, rehabilitation, and urgent assessment for the ABPN Pain Medicine certification pathway.
By CertMedbry · Updated 17 October 2026
Connect pain mechanisms to clinical decisions: distinguish neuropathic from nociceptive presentations, recognize emergencies, select safer medications, interpret diagnostic blocks, and measure functional recovery. This selective guide develops 60 concepts across every official domain. The complete November 2024 Pain Medicine Examination Content Outline defines the full scope, including topics beyond these lessons. The accompanying questions and flashcards are independently authored educational materials.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification pathway does this guide cover?
It covers ABPN initial subspecialty certification in Pain Medicine for eligible physicians certified by ABPN in psychiatry, neurology, or child neurology. ABPN applicants apply through ABPN; ABA administers the shared examination. This is physician subspecialty board certification, not general medical licensure or an American Board of Pain Medicine credential.
How do the ABA and ABPMR pathways relate to the ABPN pathway?
ABPN, ABA, and ABPMR agreed on a single certification standard. Diplomates apply through their respective boards, so shared examination content does not make their application and eligibility processes interchangeable. This guide consistently uses the ABPN initial-certification pathway; it does not describe continuing certification requirements.
How many questions are there, and how much examination time is allowed?
The published examination specifications state 200 questions and up to four hours. They do not establish a scored-versus-pretest question split. No separate scored-item count is asserted here.
ABA Pain Medicine Exam Blueprint · ABPN-linked Pain Medicine Exam Blueprint
What delivery method and question formats are published?
The ABA-administered examination is computer based. Both linked blueprints describe A-type single-best-answer questions with three response options and questions referencing static images. Adaptive delivery is not established by these specifications. This guide's 20 four-option, single-best-answer exercises are independent learning materials; their option count differs from the published official format.
ABPN — Pain Medicine · ABA Pain Medicine Exam Blueprint · ABPN-linked Pain Medicine Exam Blueprint
Which outline and blueprint dates apply?
The currently linked content outline is dated November 2024. No separate outline effective date is printed. The currently linked blueprint has no explicit version or effective date in its text. The 2023 directory in the ABA blueprint URL does not establish an effective date.
Pain Medicine Examination Content Outline — November 2024 · ABA Pain Medicine Examination Content Outline — November 2024 · ABA Pain Medicine Exam Blueprint
How is the official examination content weighted?
General accounts for 50%: Background Concepts 5%; Assessment of Pain 5%; Pharmacotherapy 15%; Procedural Treatment 15%; and Psychological, Physical, and Integrative Therapies 10%. Clinical States accounts for 50%: Taxonomy 1%; Chronic Widespread Pain Syndromes 1%; Acute/Trauma/Procedural Pain 6.5%; Musculoskeletal Pain 12.5%; Cancer Pain 6%; Visceral Pain 4%; Headache and Orofacial Pain 3%; Neuropathic Pain 8%; and Special Cases 8%. This guide uses the detailed outline's full domain names. Small question and flashcard sets necessarily round these weights and overrepresent the two 1% domains to preserve coverage.
ABA Pain Medicine Exam Blueprint · ABPN-linked Pain Medicine Exam Blueprint · Pain Medicine Examination Content Outline — November 2024
How should differences between the official documents be interpreted?
Use the detailed November 2024 contents and the administrator's blueprint for organization. The outline introduction retains an older four-section description, while its detailed contents use General and Clinical States. The ABPN-linked blueprint mislabels its clinical subdivision table as General. The blueprint says Procedural Pain where the detailed outline says Postoperative Pain; this guide uses the detailed outline wording with the blueprint's 6.5% allocation.
ABA Pain Medicine Examination Content Outline — November 2024 · ABA Pain Medicine Exam Blueprint · ABPN-linked Pain Medicine Exam Blueprint
Which eligibility and scheduling details are established?
ABPN requires qualifying primary certification by December 31 of the preceding year and 12 months of ACGME-accredited pain medicine training completed by July 31 of the examination year. Its page lists September 26, 2026 for the 2026 examination and links separately to the 2027 schedule. Consult the board's current schedule for subsequent dates, deadlines, and fees.
This guide addresses United States physician initial subspecialty certification in Pain Medicine through ABPN and the shared ABA-administered examination.
Outline used: November 2024 Pain Medicine Examination Content Outline, currently linked by ABPN and ABA and verified on 2026-10-09. The currently linked examination blueprint has no explicit version or effective date printed in its text. The workbook label maps to ABPN initial subspecialty certification in Pain Medicine through the shared ABA-administered examination; the assigned slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Background Concepts5%
1.What separates pain from nociception?
Pain is an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage. Pain is personal. Nociception is neural processing of noxious stimuli. They are related but cannot be equated: neural activity does not establish the person's experience, and pain can persist without demonstrable ongoing tissue injury. A patient's report deserves respect, while inability to communicate verbally does not exclude pain.
Apply it
A patient reports persistent burning after a healed injury, although repeat imaging shows no new damage. Assess the experience, sensory findings, function, and possible mechanisms rather than rejecting the report because structural healing has occurred.
Common pitfall: Treating normal imaging as proof of absent pain confuses tissue assessment with experience and can obstruct evaluation of neuropathic or altered nociceptive processing.
2.How do peripheral and central sensitization differ?
Peripheral sensitization increases nociceptor responsiveness and reduces thresholds in peripheral tissues. Central sensitization increases responsiveness of central nociceptive neurons to normal or subthreshold afferent input. Both can amplify pain, but their anatomical levels differ. Hyperalgesia or allodynia can suggest altered processing without independently proving a particular cellular mechanism. Distinguish the observed clinical phenomenon from an inferred mechanism, and evaluate the distribution, provoking stimulus, tissue context, and neurological findings together.
Apply it
After an ankle injury, tenderness is strongest around the injured tissue but light touch also hurts over a wider area. Describe the stimulus responses accurately and consider overlapping peripheral and central contributions rather than assigning one mechanism from tenderness alone.
Common pitfall: Using central sensitization as a synonym for unexplained pain bypasses assessment. It is a mechanism, not a conclusion established solely by normal tests.
3.How is number needed to treat calculated?
For a beneficial binary outcome, number needed to treat is the reciprocal of the absolute increase in benefit: one divided by the treatment event rate minus the control event rate. Use proportions rather than percentage points in the denominator and conventionally round upward to a whole person. Interpretation requires the outcome definition, follow-up interval, comparator, and baseline risk. Relative improvement alone cannot determine the absolute benefit for a patient population.
Apply it
In a trial, 50% of treated participants and 30% of controls achieve meaningful pain relief over eight weeks. The absolute benefit increase is 0.20, so the number needed to treat is five over that interval.
Common pitfall: Reciprocating a relative effect produces the wrong quantity. An NNT without its outcome and time horizon also invites misleading comparisons across trials.
Cochrane Handbook — Interpreting Results and Drawing Conclusions
Assessment of Pain5%
4.What distinguishes allodynia from hyperalgesia?
Allodynia is pain caused by a stimulus that does not normally provoke pain, such as gentle brushing. Hyperalgesia is increased pain from a stimulus that normally is painful, such as a pinprick. These terms describe stimulus-response relationships rather than diagnoses. Record the stimulus, distribution, and comparison with an unaffected region. The distinction supports sensory phenotyping but does not, by itself, establish neuropathic pain or identify a specific injured nerve.
Apply it
A patient says a shirt sleeve hurts against the forearm, while pinprick produces unusually intense pain nearby. Document dynamic mechanical allodynia for the brushing response and hyperalgesia for the enhanced pinprick response during the same examination.
Common pitfall: Calling every painful sensory response allodynia loses the crucial distinction between normally innocuous and normally noxious stimuli and weakens subsequent clinical interpretation.
5.How should functional outcomes shape pain assessment?
Pain intensity measures one dimension of a multidimensional experience. Assessment should also establish interference with sleep, mobility, work, relationships, and personally meaningful activities. A useful outcome is specific enough to reassess, such as walking to a nearby shop or preparing a meal. Improvement can occur through better coping and participation even when pain remains present. Interpret scores alongside adverse effects and the person's priorities rather than treating a single number as the entire outcome.
Apply it
A patient's pain score remains six, but walking tolerance doubles and sleep improves without new adverse effects. Recognize meaningful benefit, then discuss the next functional goal instead of automatically escalating medication to lower the score alone.
Common pitfall: Equating persistent pain with complete treatment failure can drive unnecessary escalation. Conversely, a lower score with disabling sedation may represent an unfavorable overall result.
VA — Cognitive Behavioral Therapy for Chronic Pain · CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
6.How should expectations and context inform assessment?
Expectations, prior experiences, mood, and treatment context can influence pain and reported benefit. Placebo-related improvement does not establish that pain was fabricated, while negative expectations can contribute to nocebo effects. An improvement after treatment may also reflect natural fluctuation or regression toward the mean. Assess these influences without dismissing symptoms, and use balanced explanations that acknowledge uncertainty while supporting realistic participation in care and repeated measurement of relevant outcomes.
Apply it
A patient feels worse after hearing that movement will inevitably damage the back, despite an unchanged examination. Explore that belief, explain the assessed findings clearly, and agree on observable activity goals while continuing appropriate clinical evaluation.
Common pitfall: Interpreting a contextual response as evidence of malingering confuses modulation with invention. Improvement after an intervention also does not automatically establish a specific biological effect.
Pain Medicine Examination Content Outline — November 2024 · VA Whole Health Library — Self-Management of Chronic Pain · IASP — Terminology
Treatment of Pain: Pharmacotherapy15%
7.How do gabapentin's target and elimination determine clinical decisions?
Gabapentin binds the alpha-2-delta subunit of voltage-activated calcium channels; it does not directly activate GABA receptors. It is eliminated through the kidneys largely unchanged. Reduced renal clearance increases exposure and prolongs elimination, making somnolence, dizziness, and impaired coordination important accumulation clues. Review the dosing regimen when kidney function changes, and assess concurrent opioids or other sedatives because combined effects can increase sedation and respiratory risk.
Apply it
A previously alert patient becomes drowsy on an unchanged gabapentin regimen after an illness reduces kidney function. The drug retains its calcium-channel binding mechanism; impaired clearance provides the explanation for increased exposure. Reassess renal dosing and other sedatives.
Common pitfall: A previously tolerated regimen can become excessive after kidney injury. Structural similarity to GABA does not establish direct GABA-receptor agonism.
8.How does acetaminophen overdose cause liver injury?
Most acetaminophen undergoes conjugation, while a smaller fraction is oxidized to the reactive metabolite NAPQI, normally detoxified by glutathione. Excess exposure can exhaust glutathione and permit hepatocellular injury. Reconcile all products because opioid combinations and cold remedies may contain acetaminophen. Suspected overdose requires urgent assessment even before symptoms develop. N-acetylcysteine supports glutathione replenishment; treatment decisions depend on exposure timing and clinical assessment rather than symptoms alone. The NAPQI–glutathione mechanism is described in the [oxycodone–acetaminophen prescribing information](https://www.dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=2426980d-f1b4-45d3-9d1a-156548a2c872&type=display); acetylcysteine prescribing information supports antidotal treatment and exposure-specific assessment.
Apply it
A postoperative patient takes a prescribed opioid-acetaminophen combination plus an over-the-counter acetaminophen product. Add the acetaminophen from both sources and assess the exposure promptly; an absence of early abdominal symptoms does not establish safety.
Common pitfall: Counting only the product labeled as a pain reliever misses duplicate ingredients. The revised Rumack–Matthew nomogram relates acetaminophen concentration to time after an acute known-time ingestion; a concentration obtained before four hours can be misleading. The nomogram does not apply to repeated supratherapeutic ingestion. For that exposure pattern, assess acetaminophen concentration, AST, ALT, INR, renal function, and clinical status to guide acetylcysteine treatment.
9.How do NSAID renal and gastrointestinal risks differ?
NSAID inhibition of prostaglandin synthesis can compromise renal blood flow when perfusion is prostaglandin dependent, especially during volume depletion, kidney impairment, heart failure, or treatment with diuretics and renin-angiotensin system inhibitors. NSAIDs can also cause gastrointestinal ulceration, bleeding, or perforation without warning symptoms. Prior ulcer bleeding, older age, anticoagulants, corticosteroids, and longer exposure increase gastrointestinal concern. Food may reduce dyspepsia but does not establish protection from serious bleeding.
Apply it
A patient with kidney disease and a previous bleeding ulcer develops vomiting while taking ibuprofen, a diuretic, and an ACE inhibitor. Reassess both acute renal perfusion risk and gastrointestinal vulnerability; tolerable stomach symptoms do not resolve either concern.
Common pitfall: Over-the-counter availability and previous tolerance do not establish safety during a new illness. Renal hemodynamic injury can develop acutely rather than only after prolonged exposure.
10.How do full and partial mu-opioid agonists differ?
Mu-opioid receptor activation inhibits neuronal signaling involved in pain transmission and modulation, while also producing effects such as respiratory depression and constipation. Morphine and fentanyl are full mu agonists. Buprenorphine is a partial mu agonist with high receptor affinity: affinity describes binding, whereas efficacy describes receptor activation. Its respiratory-depression ceiling does not eliminate overdose risk, particularly with sedatives. High affinity also does not mean that additional full agonists can never provide analgesia.
Apply it
A patient receiving buprenorphine needs surgical analgesia. Recognize its high-affinity partial agonism, maintain an individualized multimodal plan, and monitor any added opioid or sedative rather than assuming buprenorphine is either analgesically inactive or completely protective against respiratory harm.
Common pitfall: Partial agonist does not mean weak analgesic at every clinically used dose. Receptor affinity and intrinsic efficacy answer different pharmacological questions.
NCI — Cancer Pain PDQ, Health Professional Version · Buprenorphine Treatment Recommendations for Patients With Opioid Use Disorder
11.Why can antidepressants relieve neuropathic pain, and how is an agent selected?
Selected tricyclic antidepressants, such as amitriptyline and nortriptyline, and SNRIs, such as duloxetine and venlafaxine, inhibit serotonin and norepinephrine reuptake and enhance inhibitory pain modulation. Their analgesic use does not require depression, and analgesia should be assessed separately from mood response. Selection is drug specific: TCA anticholinergic effects can worsen constipation or urinary retention, and orthostasis can increase falls. An SNRI may therefore be preferable when those vulnerabilities make a TCA unsuitable.
Apply it
A patient with neuropathic cancer-related pain has stable mood, severe constipation, and orthostatic dizziness. Explain the analgesic mechanism and consider an appropriate SNRI instead of amitriptyline, while checking that agent's own contraindications, interactions, and organ-function requirements.
Common pitfall: Calling the prescription proof of a psychological cause misrepresents its purpose. An analgesic role for selected TCAs and SNRIs does not establish equivalent benefit for every antidepressant.
12.When is opioid rotation useful, and why is conversion not simple substitution?
Rotation may be considered when analgesia is inadequate despite reassessment, adverse effects are intolerable, or a different route or pharmacokinetic profile is needed. Equianalgesic estimates are starting estimates, not exact prescriptions. Incomplete cross-tolerance means tolerance to one opioid may not fully protect against another, so the new regimen generally needs a safety reduction and reassessment. Methadone conversions require particular expertise because conversion is nonlinear and accumulation can be delayed.
Apply it
A patient with cancer pain has useful morphine analgesia but persistent intolerable adverse effects. Consider a different opioid after reviewing reversible causes. Use the total current exposure to estimate a starting regimen, account for incomplete cross-tolerance, and reassess analgesia, sedation, and rescue use.
Common pitfall: Substituting the full calculated equianalgesic dose without considering cross-tolerance can cause toxicity. Persistent pain also warrants reassessment of its mechanism rather than repeated rotation without a treatment rationale.
NCI — Cancer Pain PDQ, Health Professional Version · CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
13.How should a long-term opioid taper be planned?
When opioid risks outweigh benefits, tapering should be collaborative and individualized, with attention to treatment duration, withdrawal, pain, function, and mental health. Unless a life-threatening issue requires urgent action, abrupt discontinuation or rapid reduction can cause substantial harm. A tolerable pace may require pauses and adjustment rather than a rigid schedule. Continue pain care and discuss overdose risk after loss of tolerance; reducing the prescription does not end the clinician's responsibility.
Apply it
A patient on years of opioid therapy agrees that adverse effects now outweigh benefit but develops distress during reductions. Reassess withdrawal and mental health, adjust the pace collaboratively, and maintain nonopioid pain treatment and follow-up throughout the process.
Common pitfall: Treating a guideline threshold as an automatic discontinuation order ignores individualized benefit and harm. A fixed taper pace can become unsafe when the patient's response changes.
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
14.When should naloxone accompany opioid risk mitigation?
Naloxone can reverse opioid-induced respiratory depression and should be offered when overdose risk is increased. Relevant factors include previous overdose, substance use disorder, sleep-disordered breathing, concurrent benzodiazepines, higher opioid exposure, or a likely return to use after reduced tolerance. Education should include household members when appropriate and explain emergency response. Naloxone complements medication review and safer prescribing; it does not neutralize the risks of combining opioids with other respiratory depressants.
Apply it
An outpatient receiving opioids also takes a benzodiazepine and has untreated sleep apnea. Offer naloxone and overdose education while coordinating review of the combined risks, rather than assuming a stable prescription history guarantees continued respiratory safety.
Common pitfall: Restricting naloxone to people with diagnosed opioid use disorder misses other major overdose risks. Providing it also does not justify ignoring hazardous medication combinations.
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
15.How do selected nonopioid adjuvants differ in target and limitation?
Local anesthetics such as lidocaine inhibit voltage-gated sodium channels and can reduce neural impulse conduction; topical treatment may suit localized superficial neuropathic pain. Ketamine antagonizes NMDA receptors, but a plausible sensitization mechanism does not establish routine benefit for every chronic pain condition; neuropsychiatric effects and monitoring needs matter. Corticosteroids may help selected cancer pain involving inflammation or edema, while hyperglycemia, infection risk, and other toxicities limit indiscriminate or prolonged use.
Apply it
For a small painful allodynic skin region, compare a local topical approach with the greater systemic burden of an infusion. For tumor-related edema, identify the reason a corticosteroid might help and define reassessment rather than treating all adjuvants as interchangeable analgesics.
Common pitfall: A drug's mechanistic target does not establish efficacy for every pain syndrome. Adjuvant selection still requires an indication, a measurable goal, and attention to adverse effects.
NCI — Cancer Pain PDQ, Health Professional Version · Pain Medicine Examination Content Outline — November 2024
Treatment of Pain: Procedural15%
16.Which findings suggest local anesthetic systemic toxicity?
Local anesthetic systemic toxicity can involve neurological excitation or depression and cardiovascular instability after systemic exposure. Seizures, altered consciousness, arrhythmias, or circulatory collapse during or after local anesthetic administration require immediate recognition and a toxicity-specific response. Presentations vary, so absence of a classic progression does not exclude the diagnosis. Stop local anesthetic administration, summon help, support oxygenation and ventilation, and bring the ASRA checklist and lipid emulsion into the resuscitation.
Apply it
During a regional injection, a patient develops a seizure followed by an unstable rhythm. Stop the injection and activate the local anesthetic toxicity response, recognizing the temporal connection rather than treating the event as an unrelated primary seizure.
Common pitfall: Waiting for every textbook prodrome delays treatment. Sedation or an atypical presentation can obscure early neurological symptoms before serious cardiovascular toxicity becomes apparent clinically.
ASRA Local Anesthetic Systemic Toxicity Checklist — 2020, version 1.1
17.How does LAST resuscitation differ from routine resuscitation?
ASRA's local anesthetic systemic toxicity checklist incorporates early lipid emulsion therapy alongside airway management, seizure control, and circulatory support. The response differs from standard resuscitation, including preference for smaller epinephrine doses and avoidance of vasopressin, beta-blockers, calcium-channel blockers, and additional local anesthetic drugs. Benzodiazepines are preferred for seizures. Use the current checklist for weight-dependent treatment and escalation; recalling isolated components is less reliable than coordinated use of the full cognitive aid.
Apply it
A resuscitation team recognizes cardiovascular collapse from local anesthetic toxicity. One clinician reads the ASRA checklist while others secure oxygenation, prepare lipid emulsion, and adapt resuscitation medicines to the toxicity-specific recommendations rather than applying routine drug choices automatically.
Common pitfall: Substituting propofol for lipid rescue confuses a lipid-containing formulation with the recommended antidotal treatment. Large propofol doses can worsen cardiovascular instability in this setting.
ASRA Local Anesthetic Systemic Toxicity Checklist — 2020, version 1.1
18.Why use medial branch blocks before facet radiofrequency ablation?
Lumbar facet radiofrequency ablation lesions the medial branch nerves supplying the suspected painful joints; it does not repair degeneration. A prognostic medial branch block tests whether temporarily interrupting that supply relieves the index pain and helps estimate ablation benefit. Structural degeneration alone does not establish the pain source. Society recommendations support medial branch blocks for prognostic selection, while exact block counts and relief thresholds vary across clinical, research, and coverage contexts.
Apply it
A patient with suspected lumbar facet pain asks why ablation is not selected from MRI alone. Explain the functional information supplied by a block and clarify that successful ablation may leave coexisting radicular or other pain unchanged.
Common pitfall: A favorable block changes the probability of benefit; it does not guarantee success. One relief threshold or number of blocks should not be presented as universally mandatory.
ASRA/APPD — Lumbar Facet Guideline Recommendations Slide Deck · ASRA — Facet Joint Pain
19.Why can a diagnostic facet block be falsely positive?
Relief after a facet-related block can reflect effects beyond the intended target. Local anesthetic may spread to adjacent structures, superficial anesthesia can reduce other pain, sedation can alter reporting, and reduced activity can avoid the usual provoking task. Contextual responses also contribute. Assess whether relief matches the usual index pain under representative conditions, document cointerventions, and recognize that a positive response changes probability rather than establishing an infallible diagnosis.
Apply it
A patient reports near-complete relief after a block performed with sedation but spends the afternoon resting instead of doing the activity that usually provokes pain. Interpret the result cautiously because both sedation and altered activity can inflate apparent specificity.
Common pitfall: Counting every post-block improvement as target confirmation ignores competing explanations. A technically successful injection and a diagnostically valid response are related but different judgments.
20.How do anticoagulation and infection change an elective procedural decision?
Before an elective intervention, identify the anticoagulant or antiplatelet drug, indication, last dose, renal function, and the procedure's bleeding consequences. Bleeding in a confined neuraxial space can cause neurological compression. Holding treatment also creates thrombotic risk, so interruption and resumption require a procedure-specific plan coordinated with the responsible prescriber. Use the [ASRA interventional spine and pain antithrombotic guideline](https://rapm.bmj.com/content/43/3/225.abstract) for pain-procedure risk assessment and the [ASRA regional anesthesia antithrombotic guideline](https://rapm.bmj.com/content/early/2025/01/21/rapm-2024-105766) for neuraxial and deep plexus/peripheral techniques. Infection at the needle entry site or suspected systemic infection warrants evaluation and usually postponement of an elective injection or implant. The [ASRA infection-control guideline](https://rapm.bmj.com/content/early/2025/01/14/rapm-2024-105651) addresses this clinical assessment; the examination outline establishes topic coverage. Sterile technique does not neutralize an active infection.
Apply it
A patient taking an anticoagulant for a recent thromboembolic event arrives for an elective epidural injection with fever and an inflamed entry-site lesion. Defer the procedure, assess infection, and coordinate the competing bleeding and thrombosis risks before rescheduling.
Common pitfall: A normal INR does not establish absence of every anticoagulant effect. A universal drug-holding interval ignores drug clearance, procedural risk, and the reason anticoagulation was prescribed.
21.How does pulse-rate selection reduce fluoroscopic exposure?
Pulsed fluoroscopy samples images intermittently rather than using a continuous beam. Selecting the lowest pulse rate that still provides adequate information can reduce radiation exposure, although actual dose also depends on system settings, patient size, geometry, and acquisition mode. Optimization means preserving the visibility needed for safe procedural decisions while avoiding unnecessary imaging. A lower displayed frame rate alone does not prove an equivalent proportional reduction in patient dose.
Apply it
During needle positioning, the operator can identify landmarks adequately at a lower pulse rate. Maintain that setting and use brief imaging checks, increasing temporal resolution only when the procedural task requires it rather than leaving a higher rate selected routinely.
Common pitfall: Assuming every low-pulse setting produces adequate images can compromise guidance. Conversely, choosing maximum temporal resolution by habit adds exposure without necessarily improving the decision.
22.Why collimate the fluoroscopic field?
Collimation restricts the irradiated field to the anatomy required for the task. This reduces unnecessary tissue exposure and can reduce scatter, improving image usefulness while also limiting occupational scatter exposure. It differs from simply cropping a saved image, which does not undo radiation already delivered. Optimize the field before exposure and readjust as the target changes. Radiation protection integrates field size, imaging time, equipment geometry, and suitable protective measures.
Apply it
A lumbar injection view includes much more abdomen and pelvis than needed. Narrow the beam to retain the relevant landmarks and needle trajectory before continuing imaging, rather than planning to crop the broad image afterward for documentation.
Common pitfall: Confusing digital cropping with beam collimation mistakes image presentation for exposure control. Excessively tight collimation can also remove landmarks needed to maintain safe orientation.
23.How do implanted stimulation and intrathecal delivery differ in selection and follow-up?
An intrathecal pump delivers medication into cerebrospinal fluid. It may be considered for selected refractory cancer pain when systemic opioids provide inadequate relief or intolerable adverse effects. Follow-up requires medication titration, scheduled reservoir refills, and surveillance for catheter or pump failure, infection, overdose, and withdrawal after interrupted delivery. A spinal cord stimulation system instead delivers electrical stimulation, for example for selected persistent neuropathic leg pain after spinal surgery. It requires assessment of stimulation benefit, programming, battery management, and lead or hardware complications.
Apply it
Compare a patient with refractory cancer pain and systemic opioid toxicity with a patient whose principal target is persistent neuropathic leg pain after surgery. The first may benefit from neuraxial drug delivery; the second may be considered for electrical stimulation after appropriate evaluation. Confirm access to the distinct ongoing care each system requires.
Common pitfall: A stimulator does not release morphine, and a pump requires more than hardware checks. Implantation does not end medication management or assessment of function and adverse effects.
NCI — Cancer Pain PDQ, Health Professional Version · Pain Medicine Examination Content Outline — November 2024
24.How should evidence guide regenerative procedure discussions?
A proposed regenerative intervention requires evidence specific to the product, indication, comparator, outcome, and follow-up interval. Biological plausibility and improvement in an uncontrolled series do not establish causal efficacy; natural history, contextual effects, and selection bias can explain some observed change. The outline includes products such as platelet-rich plasma and cellular preparations as topics for evaluating risks, benefits, and evidence. Its inclusion does not establish that every product is effective or interchangeable.
Apply it
A clinic promotes a cellular injection using testimonials and a laboratory mechanism. Ask whether controlled clinical evidence addresses the same preparation and condition, how large and durable the benefit is, and what harms and costs were measured.
Common pitfall: Extrapolating results from one preparation or anatomical indication to all regenerative products ignores substantial intervention differences. A promising mechanism cannot replace patient-relevant comparative evidence.
Pain Medicine Examination Content Outline — November 2024 · Cochrane Handbook — Interpreting Results and Drawing Conclusions
Treatment of Pain: Psychological, Physical, and Integrative Therapies10%
25.How does CBT for chronic pain improve function?
Cognitive behavioral therapy for chronic pain teaches skills that address the interaction among thoughts, emotions, behaviors, and pain-related disability. It supports activity, coping, and self-management rather than requiring elimination of pain before life can resume. Treatment may include cognitive restructuring, pacing, relaxation, and structured practice. Improvement is assessed through meaningful participation and reduced interference as well as pain measures. Psychological treatment is compatible with ongoing biomedical assessment and other appropriate therapies.
Apply it
A patient avoids family outings because pain might increase. CBT work identifies the feared prediction, develops a manageable activity plan, and evaluates the actual experience, helping the patient rebuild participation while other aspects of pain care continue.
Common pitfall: Explaining CBT as treatment for imaginary pain undermines its purpose. Requiring pain elimination before participation also preserves the avoidance cycle the intervention aims to change.
VA — Cognitive Behavioral Therapy for Chronic Pain · VA Whole Health Library — Self-Management of Chronic Pain
26.How does pacing interrupt the overactivity-rest cycle?
Activity pacing replaces repeated bursts of excessive activity followed by prolonged recovery with a planned, sustainable pattern. Establish a manageable baseline, break tasks into portions, and use scheduled breaks rather than waiting for severe symptom escalation. Progress should support consistency and meaningful goals. Pacing is different from avoiding all discomfort or indefinitely restricting activity: the objective is steadier participation and, when appropriate, a gradual increase in capacity over time.
Apply it
A patient cleans the entire home on a better day, then stays in bed for two days. Divide cleaning into smaller planned sessions across the week and reassess consistency before increasing the total activity load further.
Common pitfall: Using pacing as a reason to stop every activity at the first sensation of pain can reinforce avoidance. A rigid schedule also needs adjustment to actual capacity.
27.How does cognitive restructuring address catastrophic predictions?
Cognitive restructuring identifies automatic interpretations, examines their evidence, and develops a more balanced response that supports useful action. In chronic pain, a prediction such as any pain increase means fresh damage can intensify fear and avoidance. The task is not forced optimism or denial of disease. It is to distinguish a thought from an established fact, incorporate the actual medical assessment, and test a realistic alternative through safe, planned behavior.
Apply it
A patient believes that a temporary increase in familiar pain during an approved exercise proves the spine is deteriorating. Review that prediction against the clinical findings and develop a balanced statement linked to the agreed activity plan.
Common pitfall: Replacing every concern with reassurance without examining evidence misses the skill being taught. Genuine new neurological or systemic symptoms still require appropriate medical assessment.
28.Why combine active rehabilitation with coping skills?
Exercise capacity and pain-related beliefs can both limit participation. Combining active rehabilitation with coping skills addresses physical conditioning and the behavioral barriers that prevent practice. Passive treatments may provide symptom relief but do not automatically restore confidence, strength, or daily routines. Select goals that matter to the person and monitor performance over time. The treatment plan should connect each component to a functional obstacle rather than simply accumulating unrelated modalities.
Apply it
A patient receives repeated passive treatments but remains afraid to walk outside. Add an individualized walking progression and coping strategies for familiar symptom fluctuations, measuring distance and confidence rather than judging success only by immediate post-treatment pain scores.
Common pitfall: Adding more passive care without addressing avoidance can leave disability unchanged. Active rehabilitation also requires individual adaptation rather than prescribing the same exercise load to everyone.
VA — Cognitive Behavioral Therapy for Chronic Pain · VA Whole Health Library — Self-Management of Chronic Pain
29.How should return-to-work barriers be analyzed?
Work participation depends on task demands, physical capacity, beliefs about reinjury, mood, workplace flexibility, and available support. A useful rehabilitation plan identifies the specific mismatch and addresses it through coordinated functional goals, activity progression, and suitable task modifications. The official outline emphasizes vocational elements and psychosocial obstacles alongside exercise. A pain score or an imaging finding alone cannot capture all these determinants, and a functional assessment describes capacity within its testing context.
Apply it
A worker can perform short periods of light activity but fears that any return will cause permanent harm. Assess the actual job demands and beliefs, then coordinate a graded plan with feasible task changes and clearly defined review points.
Common pitfall: Waiting for zero pain before considering any work participation can prolong avoidance. Conversely, ignoring actual job hazards or essential task demands produces an unrealistic rehabilitation plan.
Pain Medicine Examination Content Outline — November 2024 · VA Whole Health Library — Self-Management of Chronic Pain
30.How should integrative treatments be evaluated?
Evaluate an integrative treatment using the same patient-relevant questions applied to other care: what outcome improves, compared with what alternative, for how long, and with what harms and costs? Separate evidence for one condition from claims across all pain syndromes. The outline includes acupuncture, mind-body approaches, and biologically based products, including their interactions. A treatment's traditional use or natural origin does not establish effectiveness, product consistency, or compatibility with prescribed medicines.
Apply it
A patient wants to add an herbal product and acupuncture. Clarify the intended goals, review the exact supplement and concurrent medicines, and discuss evidence and measurable outcomes separately for each intervention rather than endorsing them as one package.
Common pitfall: Treating all complementary approaches as either uniformly effective or uniformly ineffective ignores differences in interventions and evidence. Natural products can still create clinically important interactions.
Pain Medicine Examination Content Outline — November 2024 · Cochrane Handbook — Interpreting Results and Drawing Conclusions
Taxonomy: Classification of Pain Syndromes1%
31.What distinguishes chronic primary from chronic secondary pain?
Chronic pain persists or recurs for longer than three months. Chronic primary pain involves significant emotional distress or functional disability and is not better explained by another diagnosis. Chronic secondary pain is associated with an underlying condition, such as cancer, nerve injury, or persistent inflammation. Primary does not mean fabricated or purely psychological. Classification organizes mechanisms and clinical context; the same person can have more than one pain condition requiring separate characterization.
Apply it
A patient has disabling longstanding regional pain that is not better accounted for by another condition, alongside a separately established painful neuropathy. Classify each presentation on its evidence rather than forcing every symptom into one primary or secondary category.
Common pitfall: Diagnosing chronic primary pain solely because one scan is normal skips the required clinical assessment. Secondary disease also does not exclude additional pain amplification or distress.
Chronic Widespread Pain Syndromes1%
32.How are the 2016 revised fibromyalgia criteria applied?
The framework requires WPI at least 7 with SSS at least 5, or WPI 4–6 with SSS at least 9; generalized pain in at least four of five regions; and symptoms generally present for at least three months. The regions are left upper, right upper, left lower, right lower, and axial. Jaw, chest, and abdominal pain do not count toward the generalized-region requirement. WPI counts painful sites; SSS captures fatigue, unrefreshing sleep, cognitive symptoms, and additional symptom burden. Another illness can coexist and does not invalidate the diagnosis.
Apply it
An adult has WPI 6, SSS 9, pain in four of five regions, and symptoms at a similar level for four months. The lower-WPI pathway is satisfied, including distribution and duration. Controlled rheumatoid arthritis does not automatically exclude coexisting fibromyalgia. Combine clinical assessment with education, individualized exercise, and symptom-directed care.
Common pitfall: WPI and SSS thresholds alone are insufficient without distribution and duration. Routine imaging or blood tests do not provide a single confirmatory result, and coexisting disease still requires its own assessment.
Anx_tuto_fibromyalgie_FAI2R-wolfe2016.pdf · American College of Rheumatology — Fibromyalgia
Acute Pain, Pain due to Trauma, and Postoperative Pain6.5%
33.Why use multimodal postoperative analgesia?
Multimodal analgesia combines appropriate treatments acting through different mechanisms to improve pain control while limiting reliance on any single drug. Options may include nonopioid medicines, regional or local techniques, and selected opioid rescue. The combination must fit the operation, comorbidities, and recovery goals. Success includes comfortable movement, sleep, and participation in rehabilitation, not simply a low resting pain score. Combining medicines is purposeful only when their expected contributions and risks are understood.
Apply it
After orthopedic surgery, a patient needs enough analgesia to transfer and participate in therapy. Develop a compatible combination of nonopioid, regional, and rescue options, accounting for renal and gastrointestinal risks rather than escalating one medicine without reassessment.
Common pitfall: Calling any collection of prescriptions multimodal can hide duplicate mechanisms or additive toxicity. Opioid reduction is useful only when pain control and recovery remain clinically adequate.
AAOS OrthoInfo — Managing Orthopaedic Surgery-Related Pain With Medications
34.How should postoperative analgesic benefit be measured?
Postoperative assessment should connect pain relief to recovery tasks while checking adverse effects. Resting pain, movement-evoked pain, alertness, breathing, nausea, and ability to participate in the planned recovery pathway provide different information. A patient who is comfortable only because of marked sedation has not achieved an acceptable balance. Reassess after interventions and when clinical status changes, and distinguish expected surgical discomfort from a new problem requiring a separate evaluation.
Apply it
A patient reports little resting pain but cannot stay awake for physiotherapy after an analgesic increase. Reassess the regimen and sedation rather than documenting the low score as sufficient evidence of successful postoperative pain management that day.
Common pitfall: Using a resting pain number as the sole endpoint overlooks movement and toxicity. A new pain pattern should not automatically trigger more analgesic without examination.
AAOS OrthoInfo — Managing Orthopaedic Surgery-Related Pain With Medications · Pain Medicine Examination Content Outline — November 2024
35.How do regional techniques fit postoperative recovery?
Regional and local anesthetic techniques can reduce pain transmission from the operative region and contribute to a broader analgesic plan. Their effects and limitations depend on the technique and anatomical coverage; they do not remove the need for reassessment, systemic medication review, or a plan as the effect subsides. Discuss expected changes in sensation and movement, recovery precautions, and the patient's route to assistance if symptoms or analgesia differ from expectations.
Apply it
A patient receiving a regional technique asks whether all other pain planning is unnecessary. Explain its expected area and duration of benefit, coordinate compatible medicines, and establish how pain will be reassessed during recovery and after the effect decreases.
Common pitfall: Assuming a regional technique covers every pain source can leave important symptoms untreated. Unexpected findings require evaluation rather than automatic attribution to the block.
AAOS OrthoInfo — Managing Orthopaedic Surgery-Related Pain With Medications · Pain Medicine Examination Content Outline — November 2024
36.Why does discharge education affect postoperative safety?
A discharge analgesic plan must be understandable enough for the patient or caregiver to use correctly. Explain each medicine's purpose, how scheduled and rescue treatments differ, important adverse effects, and how ongoing use will be reassessed. Medication reconciliation should identify overlapping products and sedating combinations. Recovery goals provide context for treatment, while clear contact instructions support timely assessment when pain or side effects depart from the expected course.
Apply it
A patient leaves with a combination analgesic and also plans to use several home pain products. Reconcile ingredient lists, clarify the intended schedule and rescue role, and use teach-back to check that the patient can explain the plan.
Common pitfall: Providing several prescriptions without checking understanding can create duplicate exposure. A written handout alone does not establish that the patient can safely apply the instructions.
AAOS OrthoInfo — Managing Orthopaedic Surgery-Related Pain With Medications · CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Musculoskeletal Pain12.5%
37.When does back pain suggest cauda equina syndrome?
New bladder dysfunction, saddle sensory change, or progressive lower-limb neurological deficits in a patient with back or leg pain can indicate cauda equina compression. Urinary retention is particularly concerning; overflow leakage can be mistaken for ordinary incontinence. This pattern requires emergency evaluation because delayed treatment can leave permanent neurological impairment. The decision rests on the neurological and sphincter features, not on whether the pain score is exceptionally high or a previous scan was reassuring.
Apply it
A patient with lumbar pain develops difficulty initiating urination and numbness around the perineum. Arrange emergency assessment for possible cauda equina syndrome rather than booking routine physical therapy or waiting to see whether additional analgesia improves the symptoms.
Common pitfall: Explaining new urinary symptoms as medication effects without evaluating the associated saddle or neurological findings can delay recognition of a time-critical compressive syndrome.
38.What separates radicular pain from radiculopathy?
Radicular pain describes pain arising from involvement of a spinal nerve root or its ganglion. Radiculopathy denotes impaired root function, demonstrated by findings such as weakness, sensory loss, or reflex change in a compatible pattern. They can coexist, but pain radiation alone does not establish a neurological deficit. Build localization from the history and examination, then use investigations to address a defined question rather than treating every radiating symptom as equivalent root dysfunction.
Apply it
One patient has shooting leg pain without objective deficit; another also has compatible weakness and reflex reduction. Describe the first presentation as radicular pain when supported, while recognizing the additional evidence of radiculopathy in the second patient's examination.
Common pitfall: Using sciatica, referred pain, and radiculopathy interchangeably loses diagnostic precision. A radiating pain description alone does not identify the affected root or prove functional impairment.
IASP — Definitions of Chronic Pain Syndromes · Pain Medicine Examination Content Outline — November 2024
39.Why does facet degeneration on imaging not establish the pain source?
Imaging identifies structural changes, but visible facet degeneration does not by itself establish that the joint generates the patient's current pain. Clinical symptoms can arise from multiple structures, and degeneration may be present without matching symptoms. History, examination, alternative explanations, and appropriately interpreted prognostic procedures provide different kinds of evidence. Avoid converting an anatomical description into a causal diagnosis without considering whether the findings explain the patient's specific pain and functional limitations.
Apply it
A lumbar MRI shows facet arthropathy, but the patient also has leg symptoms and sensory changes. Evaluate the neurological presentation and competing sources rather than selecting facet treatment solely because the report contains the word arthropathy in its impression.
Common pitfall: Treating the most prominent imaging abnormality as the painful structure can lead to mismatched procedures. Normal or mild imaging also does not quantify the person's pain.
40.How does exercise support knee osteoarthritis care?
Knee osteoarthritis management commonly includes individualized exercise to improve strength, range of motion, and function. Choose activities compatible with symptoms and ability, and modify loads rather than equating all discomfort with joint damage. Lower-impact options can help maintain participation when higher-impact activity is poorly tolerated. Exercise does not regenerate lost cartilage, but structural reversal is not required for functional benefit. Weight management and other nonsurgical measures may complement the activity plan when relevant.
Apply it
A patient stops all exercise after a knee osteoarthritis diagnosis. Discuss an achievable strengthening and lower-impact activity program, tracking stair use and walking tolerance while adapting the plan to symptoms and the person's existing functional capacity over time.
Common pitfall: Prescribing complete rest because cartilage is worn can worsen conditioning. Promising that exercise will rebuild the joint also misstates its expected clinical benefit and purpose.
41.How should medication risks shape knee osteoarthritis treatment?
Medication selection for knee osteoarthritis requires balancing symptom relief with the patient's gastrointestinal, renal, cardiovascular, and other risks. A treatment that helps pain may still be unsuitable when comorbidities or interacting medicines increase harm. Integrate medication with exercise, activity modification, and other appropriate nonsurgical measures rather than treating a prescription as the entire plan. Reassess function and adverse effects to determine whether the chosen approach provides worthwhile benefit for that individual.
Apply it
A patient with knee osteoarthritis, kidney impairment, and previous ulcer bleeding requests regular oral ibuprofen. Review those risks and compatible alternatives while retaining an individualized rehabilitation plan, rather than assuming the arthritis diagnosis makes an NSAID automatically appropriate.
Common pitfall: Choosing medication from the diagnosis alone overlooks patient-specific contraindications and competing risks. Symptom improvement does not erase emerging toxicity or justify abandoning functional rehabilitation.
AAOS OrthoInfo — Arthritis of the Knee · DailyMed — Ibuprofen Prescribing Information
42.Which clues distinguish osteoarthritis from inflammatory arthritis?
Load-related pain, crepitus, restricted movement, and degenerative radiographic changes such as joint-space narrowing and osteophytes support osteoarthritis. Persistent synovitis, prolonged stiffness after rest, and a symmetric multiple-joint pattern raise concern for inflammatory disease such as rheumatoid arthritis. Swelling can occur in osteoarthritis and is insufficient alone to distinguish the conditions. Compare distribution, course, examination, and imaging rather than using pain severity or the word arthritis as the diagnosis.
Apply it
A patient with knee crepitus and load-related pain develops persistent swelling of both wrists and several metacarpophalangeal joints, with prolonged morning stiffness. Reassess for inflammatory arthritis instead of attributing the new symmetric pattern to the established knee osteoarthritis.
Common pitfall: An effusion does not automatically establish rheumatoid arthritis. Conversely, degenerative knee changes do not explain persistent symmetric synovitis elsewhere or exclude coexisting inflammatory disease.
43.How should persistent back pain rehabilitation be targeted?
Persistent back pain rehabilitation should address the person's activity limitations, conditioning, beliefs, sleep, and participation barriers alongside assessment of the clinical pain presentation. Structural findings alone do not determine disability or the most useful rehabilitation goal. A combined physical and psychological approach can link graded activity with coping and self-management skills. Define observable tasks and reassess progress, while remaining alert to new findings that require a different diagnostic or urgent pathway.
Apply it
A patient with stable longstanding back pain avoids walking because movement is expected to cause damage. After appropriate assessment, combine a manageable walking plan with work on that prediction, measuring participation rather than ordering repeated imaging solely for persistent symptoms.
Common pitfall: Offering reassurance without a practical activity plan may leave avoidance unchanged. Treating every later symptom as the same chronic problem can also obscure a new condition.
VA Whole Health Library — Self-Management of Chronic Pain · Pain Medicine Examination Content Outline — November 2024
Cancer Pain and Cancer-related Pain6%
44.What does anticipatory management of opioid-induced constipation include?
Opioids reduce gastrointestinal motility, and tolerance to constipation is often limited. When regular opioids are started, assess baseline bowel function and initiate a scheduled bowel regimen, for example a stimulant laxative such as senna, with reassessment and addition of an osmotic agent when appropriate. Hydration and mobility can support care but may be insufficient alone. Persistent symptoms despite laxatives may warrant a peripherally acting mu-opioid receptor antagonist after evaluating obstruction, impaction, and other causes.
Apply it
A patient starting morphine receives scheduled senna and follow-up of stool frequency, consistency, and discomfort. If constipation persists, reassess adherence and add appropriate treatment. New distension, vomiting, colicky pain, or suspected impaction changes the assessment before escalation to a peripheral opioid antagonist.
Common pitfall: Waiting for severe constipation increases avoidable burden. Suspected obstruction requires assessment; simply adding laxatives or a peripheral opioid antagonist can be inappropriate and potentially harmful.
45.When can radiation help painful bone metastases?
Radiation can provide pain relief from bone metastases by treating the painful tumor site. It complements systemic analgesia rather than functioning as an immediate rescue medicine or a treatment for every pain mechanism. Selection considers the location, prior treatment, overall clinical situation, and goals. Assess symptoms suggesting fracture or neurological compression separately because these may require urgent multidisciplinary decisions. Persistent focal metastatic pain should prompt consideration of disease-directed palliation as well as medication adjustment.
Apply it
A patient has persistent focal pain from a documented bone metastasis despite a reasonable analgesic regimen. Discuss radiation oncology assessment while continuing symptom treatment, rather than assuming that only progressively higher opioid exposure can address the painful site.
Common pitfall: Expecting immediate analgesia from radiation can leave symptoms undertreated during the interval to benefit. New weakness or suspected fracture requires assessment beyond routine radiation referral.
NCI — Cancer Pain PDQ, Patient Version · NCI — Cancer Pain PDQ, Health Professional Version
46.How do cancer pain mechanisms guide assessment?
Cancer pain can arise from tumor involvement of bone, viscera, or neural structures and from treatment-related injury. More than one mechanism may coexist, so a cancer diagnosis does not make every pain symptom equivalent. Characterize location, timing, provoking factors, sensory qualities, neurological findings, and treatment history. Matching the presentation to plausible mechanisms helps identify suitable analgesic, adjuvant, interventional, or disease-directed options while preserving attention to a new cancer-related emergency.
Apply it
A patient has deep focal pelvic pain plus burning feet after chemotherapy. Assess these as potentially different pain mechanisms with different contributors and treatment targets instead of treating both as a single indication to increase the background opioid alone.
Common pitfall: Attributing every symptom to tumor progression can miss treatment toxicity or unrelated disease. Conversely, familiar chronic pain should not obscure a new neurological or skeletal complication.
47.What separates breakthrough pain from uncontrolled background pain?
Breakthrough cancer pain is a transient exacerbation occurring despite otherwise adequately controlled background pain. Its pattern may be linked to activity, occur unpredictably, or relate to other identifiable circumstances. Persistent pain throughout the day suggests a different problem with baseline control rather than repeated isolated breakthroughs. Clarify timing, triggers, duration, medication response, and the overall regimen. That distinction informs whether to reconsider background therapy, address a predictable trigger, or plan appropriate episodic treatment.
Apply it
A patient is comfortable at rest but has brief severe pain during transfers. Another reports continuous pain between every rescue dose. Distinguish movement-related episodes from inadequate background control before deciding which part of each analgesic plan needs reassessment.
Common pitfall: Calling every request for additional analgesia breakthrough pain can conceal inadequate baseline treatment. Increasing background medication for brief predictable episodes may also increase unnecessary sedation.
Visceral Pain4%
48.Why can visceral pain be referred to somatic regions?
Visceral and somatic inputs can converge within shared central processing pathways, allowing pain from an internal organ to be perceived in a somatic region. Visceral pain may be diffuse and poorly localized, so the perceived site does not reliably identify the tissue of origin. Interpret referral patterns alongside organ-related symptoms, examination, and appropriate investigations. Referred pain does not require a lesion in the peripheral nerve serving the perceived painful skin or muscle.
Apply it
A patient with an established visceral disorder reports pain at a distant somatic site without a corresponding local lesion. Consider a referral mechanism while still evaluating whether the new presentation has features suggesting a separate condition that needs investigation.
Common pitfall: Diagnosing peripheral neuropathy solely because pain is felt away from the diseased organ confuses referral with nerve injury. Familiar referral patterns are clues rather than definitive diagnoses.
IASP — Definitions of Chronic Pain Syndromes · Pain Medicine Examination Content Outline — November 2024
49.When is celiac plexus intervention anatomically relevant?
Celiac plexus interventions can address selected upper abdominal visceral pain, including pain associated with pancreatic cancer. The anatomical target is not a universal pathway for every abdominal symptom: abdominal wall pain, pelvic pain, or other mechanisms may require different approaches. Selection considers the suspected pain source, prior treatment, anticipated benefit, procedural risks, and goals. Neurolytic treatment interrupts neural transmission and should not be described as treatment of the underlying tumor itself.
Apply it
A patient with pancreatic cancer has persistent upper abdominal visceral pain despite medication and burdensome adverse effects. Discuss whether celiac plexus intervention fits the pain mechanism, while evaluating any separate abdominal wall pain as a different treatment target.
Common pitfall: Choosing a plexus procedure from the word abdominal alone ignores anatomy and mechanism. A successful intervention may reduce selected pain without eliminating every symptom or analgesic requirement.
Headache and Orofacial Pain3%
50.How are primary headache patterns distinguished from triptan-overuse headache?
Migraine commonly produces disabling pulsating pain aggravated by routine activity with nausea or light and sound sensitivity. Tension-type headache more often produces bilateral pressing pain without activity aggravation or vomiting. Cluster headache produces severe unilateral orbital or temporal attacks with ipsilateral autonomic features and restlessness. Triptan-overuse headache requires a pre-existing headache disorder, headache on at least 15 days monthly, triptan use on at least 10 days monthly for more than three months, and no better explanatory ICHD-3 diagnosis.
Apply it
A patient with migraine has 20 headache days monthly and uses a triptan on 12 days monthly for four months. The numerical thresholds are satisfied, but complete the diagnostic assessment, including competing causes. Use a diary to record headache days and medication-use days separately; coexisting migraine and medication-overuse headache may both be diagnosed.
Common pitfall: Meeting frequency and duration thresholds does not complete the exclusion assessment. Count treatment days rather than tablets, and do not apply the 15-day nonopioid-analgesic threshold to triptans.
Pain Medicine Examination Content Outline — November 2024 · 8.2 Medication-overuse headache (MOH) - ICHD-3 · ICHD-3 — Triptan-Overuse Headache
51.Which features distinguish representative orofacial pain syndromes?
Brief unilateral electric-shock facial attacks triggered by innocuous contact, chewing, or brushing teeth suggest trigeminal neuralgia in a trigeminal distribution. ICHD-3 specifies severe paroxysms typically lasting a fraction of a second to two minutes and precipitated by innocuous stimuli. Jaw pain modified by chewing or opening, with reproduction of familiar pain over the temporomandibular joint or masticatory muscles, supports a pain-related temporomandibular disorder under the [DC/TMD diagnostic publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC4884471/). Pain localized to a tooth with thermal sensitivity or biting tenderness warrants dental assessment. Persistent sensory loss, an atypical distribution, or other neurological findings increase concern for a secondary neural lesion and change the evaluation.
Apply it
Compare seconds-long cheek shocks triggered by a light touch with an aching jaw pain reproduced by opening and masseter palpation. The first suggests a neuralgic pattern; the second suggests a musculoskeletal jaw source. Match examination and investigations to that distinction before selecting dental, medication, or procedural treatment.
Common pitfall: Facial pain does not automatically establish dental disease or trigeminal neuralgia. Irreversible dental or neuroablative treatment requires a supported target rather than a symptom location alone.
13.1 Pain attributed to a lesion or disease of the trigeminal nerve - ICHD-3
Neuropathic Pain8%
52.What evidence supports a neuropathic pain mechanism?
Neuropathic pain is caused by a lesion or disease of the somatosensory nervous system. Burning, electric sensations, allodynia, or tingling can be suggestive but are not independently sufficient. Seek a plausible neurological history, a neuroanatomically credible distribution, compatible sensory findings, and evidence supporting the relevant lesion or disease when available. Distinguish a symptom descriptor from a mechanism and recognize that nociceptive and neuropathic contributors can coexist in one clinical presentation.
Apply it
A patient describes burning foot pain with distal sensory loss and an established polyneuropathy. This combination supports a neuropathic mechanism more strongly than burning pain alone in a patient whose distribution and neurological evaluation do not support a somatosensory lesion.
Common pitfall: Diagnosing neuropathic pain from an adjective alone overstates certainty. Conversely, requiring dramatic weakness can miss pain associated primarily with sensory nerve involvement or disease.
IASP — Terminology · IASP — Definitions of Chronic Pain Syndromes
53.How do central and peripheral neuropathic pain differ?
The distinction depends on the location of the lesion or disease causing somatosensory dysfunction. Peripheral neuropathic pain arises from peripheral nervous system involvement; central neuropathic pain arises from a central somatosensory lesion or disease. Pain intensity, burning quality, or distress does not determine this classification. Relate symptoms to the known lesion and examination, and avoid assuming that any pain after a neurological event must be neuropathic, because musculoskeletal and other causes can coexist.
Apply it
A person after stroke develops pain with sensory abnormalities corresponding to the affected central pathway but also has shoulder pain provoked mechanically. Evaluate the two presentations separately rather than classifying every painful symptom as central neuropathic pain because a stroke occurred.
Common pitfall: Using central to mean severe, emotional, or unexplained confuses anatomy with interpretation. A neurological diagnosis alone does not establish the mechanism of every subsequent pain complaint.
IASP — Terminology · IASP — Definitions of Chronic Pain Syndromes
54.How are the Budapest clinical criteria for CRPS applied?
The Budapest clinical criteria require continuing regional pain disproportionate to the inciting event; at least one reported symptom in three of four categories; at least one observed sign in two categories at evaluation; and no better explanatory diagnosis. Categories are sensory, vasomotor, sudomotor/edema, and motor/trophic. Sensory symptoms include hyperesthesia or allodynia; sensory signs include pinprick hyperalgesia or allodynia. Other categories include temperature or color asymmetry; sweating change or edema; and decreased range of motion, motor dysfunction, or trophic changes. Reported historical features and current observed signs must be counted separately. The numerical requirements are specified in Appendix II of [Harden et al., the original Budapest criteria validation publication](https://baycrest.echoontario.ca/wp-content/uploads/2018/02/Validation-of-proposed-diagnostic-criteria-the-Budapest-Criteria-for-Complex-Regional-Pain-Syndrome.pdf).
Apply it
After a healed fracture, a patient has disproportionate regional pain and reports touch sensitivity, color change, swelling, and stiffness. Touch sensitivity, color change, and swelling supply sensory, vasomotor, and sudomotor/edema symptoms. Examination shows brush allodynia and edema, providing two sign categories. The requirements are met without counting nonspecific stiffness as a motor/trophic symptom, provided no alternative diagnosis better explains the presentation.
Common pitfall: Severe pain alone is insufficient, and a history of swelling cannot substitute for an observed sign at evaluation. Infection, vascular disease, focal neuropathy, and other explanations must be considered.
55.Why emphasize functional restoration in CRPS care?
CRPS can produce pain, guarding, reduced movement, and substantial loss of limb function. Treatment commonly combines rehabilitation with symptom management and support for coping, rather than waiting for complete pain relief before addressing use of the limb. Physical and occupational approaches can support movement and daily tasks, with adaptation to tolerance and clinical findings. Medicines or procedures are components of a broader plan, and their value should include whether they facilitate meaningful functional progress.
Apply it
A patient with CRPS avoids all hand use while waiting for medication to eliminate pain. Coordinate a tolerable rehabilitation plan and symptom treatment, tracking achievable tasks such as grooming or handling light objects rather than postponing every activity indefinitely.
Common pitfall: Equating rehabilitation with forcing painful activity ignores the need for adaptation. Relying exclusively on a procedure can also leave important functional and behavioral barriers untreated.
AAOS OrthoInfo — Complex Regional Pain Syndrome · Pain Medicine Examination Content Outline — November 2024
Special Cases8%
56.How should perioperative care address maintenance buprenorphine?
Multisociety recommendations advise that buprenorphine for opioid use disorder should not be routinely discontinued in the perioperative period, because interruption can increase recurrence-related harm. Plan analgesia using multimodal measures and regional techniques when appropriate, with additional treatment individualized to the operation and response. Coordinate with the outpatient prescriber and provide a clear transition plan. Continuing treatment for opioid use disorder and providing adequate acute pain care are compatible goals, not mutually exclusive obligations.
Apply it
A patient stable on buprenorphine for opioid use disorder is scheduled for surgery. Coordinate the perioperative plan with the prescriber, retain continuity unless individualized circumstances justify a change, and anticipate additional multimodal analgesia rather than stopping treatment by routine.
Common pitfall: Assuming buprenorphine makes postoperative analgesia impossible can prompt unnecessary interruption. Continuing it also does not mean that the maintenance regimen alone will cover every surgical pain requirement.
ASRA — Buprenorphine Management in the Perioperative Period · Buprenorphine Treatment Recommendations for Patients With Opioid Use Disorder
57.How should pain be assessed when speech is limited?
Inability to communicate verbally does not exclude pain. Attempt an accessible form of self-report when possible, and supplement it with behavioral observation, examination, clinical context, and caregiver knowledge of usual behavior. Changes in movement, facial expression, participation, or comfort can support assessment but are not perfectly specific. Reassess after an appropriate intervention while continuing to consider other causes of distress. A caregiver's interpretation contributes information without replacing all direct patient assessment.
Apply it
A nonverbal adult becomes guarded during transfers and withdraws from usual activities. Compare with baseline behavior, examine for plausible causes, seek caregiver observations, and reassess comfort and function after treatment rather than documenting absence of pain because no score is spoken.
Common pitfall: Equating silence with comfort misses pain. Assuming every behavior change is painful also overlooks other causes, so observation must remain linked to examination and clinical context.
IASP — Terminology · Pain Medicine Examination Content Outline — November 2024
58.Why must pediatric assessment match developmental ability?
Pain assessment in children should match developmental and cognitive ability rather than chronological age alone. Use an understandable self-report approach when feasible, with suitable observational methods and family input when communication is limited. Prior experiences, anxiety, and family beliefs can influence expression without making the pain less real. The official outline emphasizes these developmental distinctions and school participation. Adult communication assumptions and adult medication expectations should not simply be transferred to a child.
Apply it
A child cannot reliably use the numerical scale offered during a visit but can communicate in simpler ways. Adapt the assessment to demonstrated ability, incorporate observed behavior and caregiver context, and check understanding rather than interpreting an inconsistent number as absence of pain.
Common pitfall: Choosing a tool solely from the child's age can exceed actual comprehension. Caregiver concern is valuable but should complement the child's own communication whenever it is feasible.
Pain Medicine Examination Content Outline — November 2024 · IASP — Terminology
59.How are physiological opioid adaptation and opioid use disorder distinguished?
Physical dependence can produce withdrawal after stopping or substantially reducing an opioid. Tolerance is reduced response after repeated exposure. Opioid use disorder requires a problematic pattern causing clinically significant impairment or distress; tolerance and withdrawal during appropriate medical treatment do not independently establish it. Assess loss of control, consequences, and the full diagnostic context. In older adults, also distinguish withdrawal or intoxication from new illness, and review organ function, interactions, cognition, and balance before attributing change to age.
Apply it
An older patient develops sweating and diarrhea after abruptly missing prescribed opioids but reports no loss of control or harmful use pattern. Recognize possible withdrawal and perform a complete assessment. A separate episode of new drowsiness after kidney injury warrants review for medication accumulation rather than an automatic addiction diagnosis.
Common pitfall: Dependence does not establish opioid use disorder or require indefinite continuation. Neither age nor a stable prescribing history replaces reassessment of benefit, function, and safety.
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 · Pain Medicine Examination Content Outline — November 2024
60.How do access barriers alter a feasible pain plan?
An effective plan must be feasible within the patient's language, transport, financial, housing, work, and caregiving circumstances. The official outline treats disparities, social determinants, and access as substantive practice issues. Identify the actual obstacle before interpreting missed visits or incomplete therapy as unwillingness. Shared decisions can adapt delivery, goals, and follow-up while preserving appropriate clinical standards. Document the barrier and the response so that coordination addresses a system problem rather than repeating an inaccessible recommendation.
Apply it
A patient repeatedly misses rehabilitation because the only available sessions conflict with hourly work and transport is unreliable. Clarify the obstacle and coordinate feasible scheduling or delivery options instead of concluding that persistent disability proves a lack of motivation.
Common pitfall: Labeling structural barriers as nonadherence can reproduce the same ineffective plan. Adaptation should be based on the individual's circumstances rather than assumptions about a social or cultural group.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give pharmacotherapy and procedural reasoning sustained attention: together they account for 30% of the official blueprint. Explain drug targets, toxicity, opioid conversion uncertainty, bleeding and infection risks, and maintenance requirements.
- Practise neurological localization and emergency discrimination in musculoskeletal presentations, especially sphincter symptoms, saddle sensory change, and new neurological deficits.
- Apply operational criteria for fibromyalgia, CRPS, and medication-overuse headache. Separate numerical thresholds, reported symptoms, observed signs, duration, and competing diagnoses.
- Interpret prognostic blocks probabilistically: separate target-specific relief from sedation, spread, altered activity, and contextual effects.
- Use functional outcomes across assessment, rehabilitation, postoperative recovery, and medication review, while distinguishing dependence from opioid use disorder and outpatient noncancer guidance from cancer care.
- Retain coverage of small domains and study the complete official outline for additional anatomy, medications, headache and orofacial syndromes, legal issues, practice management, and quality improvement.
A practical preparation plan
1. Build a weighted outline map
Use the November 2024 detailed outline as the master scope. Divide study time broadly between General and Clinical States, then emphasize the larger subdivisions without omitting the smaller ones.
2. Explain mechanisms before memorizing treatments
For each presentation, state the likely pain mechanism, supporting findings, and a competing explanation. For each medicine or procedure, identify its target, important risks, and the outcome that would justify continuing it.
3. Apply criteria to scored cases
Calculate WPI and SSS combinations, count CRPS symptom and sign categories separately, and record headache days apart from medication-use days. Check distribution, duration, and competing explanations before assigning a diagnosis.
4. Connect treatment to participation
Write one measurable functional goal for each mini-case. Practise integrating active rehabilitation, coping skills, medication safety, and patient circumstances into a coherent plan.
5. Use the drills diagnostically
Answer the 20 questions without notes, then explain why every competing option is less appropriate. Use missed distinctions to guide review; the score is a learning signal rather than a certification pass prediction.
6. Complete the scope beyond this guide
Revisit the full outline for uncovered topics and use the flashcards for spaced recall. Keep application and examination logistics separate from clinical study, using the responsible board's current information.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ABPN — Pain Medicine
- ABA — Pain Medicine Exam
- Pain Medicine Examination Content Outline — November 2024
- ABA Pain Medicine Examination Content Outline — November 2024
- ABPN-linked Pain Medicine Exam Blueprint
- ABA Pain Medicine Exam Blueprint
- Cochrane Handbook — Interpreting Results and Drawing Conclusions
- IASP — Terminology
- IASP — Definitions of Chronic Pain Syndromes
- DailyMed — Gabapentin Prescribing Information
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
- DailyMed — Ibuprofen Prescribing Information
- ASRA Local Anesthetic Systemic Toxicity Checklist — 2020, version 1.1
- ASRA/APPD — Lumbar Facet Guideline Recommendations Slide Deck
- ASRA — Facet Joint Pain
- IAEA Human Health Series No. 48 — Quality Assurance and Optimization for Fluoroscopically Guided Interventional Procedures
- VA — Cognitive Behavioral Therapy for Chronic Pain
- VA Whole Health Library — Self-Management of Chronic Pain
- American College of Rheumatology — Fibromyalgia
- AAOS OrthoInfo — Managing Orthopaedic Surgery-Related Pain With Medications
- AAOS OrthoInfo — Cauda Equina Syndrome
- AAOS OrthoInfo — Arthritis of the Knee
- NCI — Cancer Pain PDQ, Health Professional Version
- NCI — Cancer Pain PDQ, Patient Version
- ICHD-3 — Triptan-Overuse Headache
- AAOS OrthoInfo — Complex Regional Pain Syndrome
- ASRA — Buprenorphine Management in the Perioperative Period
- ASRA — Buprenorphine Treatment Recommendations for Patients With Opioid Use Disorder
- Checklist for Treatment of Local Anesthetic Systemic Toxicity (LAST)
- Anx_tuto_fibromyalgie_FAI2R-wolfe2016.pdf
- 8.2 Medication-overuse headache (MOH) - ICHD-3
- Buprenorphine Treatment Recommendations for Patients With Opioid Use Disorder
- PART_I-C.pdf
- DailyMed - ACETYLCYSTEINE injection, solution
- 207916Orig1s000OtherR.pdf
- 2.2 Frequent episodic tension-type headache - ICHD-3
- 13.1 Pain attributed to a lesion or disease of the trigeminal nerve - ICHD-3
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.